Clinical trial Recruiting at 1 site Interventional Ages 18 to 50

Evaluating Doxycycline Nanoparticles with Gelatin Sponge for Immediate Dental Implants

Official title: Clinical and Radiographic Evaluation of Doxycycline and Doxycycline Loaded Nanoparticles With Gelatin Sponge on Immediate Implant Placement in Esthetic Zone: A Randomized Clinical Trial

Run by Kafrelsheikh University · NCT06809829 · Data updated 2026-11-12

This study tests if using doxycycline nanoparticles with a gelatin sponge can improve the success of immediate dental implants compared to standard treatment for patients getting implants in the front of their mouth.

Quick facts

Study typeInterventional
Ages18 Years to 50 Years
SexAll
Enrollment16 (estimated)
SponsorKafrelsheikh University
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Kafrelsheikh, Kafrelsheikh)
StatusRecruiting
StartedFebruary 2025
Main results expectedJuly 2026
Study endsFebruary 2027
Registry record updatedFebruary 5, 2025
Trial IDNCT06809829 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals with non-restorable single-rooted maxillary teeth who have sufficient bone volume and good oral hygiene.

Probably not a fit

Patients with insufficient bone volume, active infections, or systemic disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to assess the effectiveness of doxycycline nanoparticles combined with a gelatin sponge in enhancing the outcomes of immediate dental implant placements in the esthetic zone. The study will involve two groups of patients: one receiving implants with doxycycline-loaded nanoparticles and gelatin sponge, and the other receiving implants with standard doxycycline and gelatin sponge. Researchers will compare clinical and radiographic results between these two groups to determine if the nanoparticle formulation provides superior benefits.

Why it matters

Potential benefit: If successful, this approach could lead to improved healing and aesthetic outcomes for patients receiving immediate dental implants.

How similar studies have gone: While the use of nanoparticles in dental applications is emerging, this specific combination of doxycycline nanoparticles and gelatin sponge for immediate implants is relatively novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* The presence of non-restorable single-rooted maxillary centrals, canines or premolars.
* Sufficient bone volume.
* Good oral hygiene.
* The remaining space between the socket and the fixture equals or more than 2mm at the coronal third of the socket.
* Sufficient bone width (≥ 1 mm) in the buccal plate of the remaining bone to place an implant confirmed by cone beam computer tomography (CBCT).

Exclusion Criteria:

* Insufficient bone volume.
* Active infection.
* Patients on chemotherapy or radiotherapy.
* Patients who have systemic disorders {uncontrolled diabetes mellitus, autoimmune disease, …etc},
* Pregnant patients,
* Patients with bone diseases
* Presence of periapical pathology affecting the neighbouring teeth.
* Smokers.

Where it's running

  • Faculty of dentistry kafrelsheikh university
    Kafrelsheikh, Kafrelsheikh, Egypt
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.